Pedro Sánchez-Rovira

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Squamous Cell Carcinoma

Epidermal Growth Factor Receptor

Ejection Fraction

Top Venues

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Lucjan Wyrwicz, Cesar A Rodriguez, Pedro Sánchez-Rovira, Sandra Lewis, Darcie Sandschafer, Tevy San
Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union. Future oncology (London, England) 20 (13) (2024)
Lucjan Wyrwicz, Cesar A Rodriguez, Pedro Sánchez-Rovira, Sandra Lewis, Darcie Sandschafer, Tevy San
Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union. Future oncology (London, England) (2024)
Lucjan Wyrwicz, Cesar A Rodriguez, Pedro Sánchez-Rovira, Sandra Lewis, Darcie Sandschafer, Tevy San
Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union. Future oncology (London, England) 20 (13) (2024)